相似文献
1
Prevalence of nontuberculous mycobacteria infection, China, 2004-2009.
Emerg Infect Dis. 2012 Mar;18(3):527-8. doi: 10.3201/eid1803.110175.
2
Prevalence and drug resistance of nontuberculous mycobacteria, northern China, 2008-2011.
Emerg Infect Dis. 2014 Jul;20(7):1252-3. doi: 10.3201/eid2007.131801.
3
Prevalence and species spectrum of both pulmonary and extrapulmonary nontuberculous mycobacteria isolates at a tertiary care center.
Int J Mycobacteriol. 2016 Sep;5(3):288-293. doi: 10.1016/j.ijmyco.2016.06.008. Epub 2016 Jun 27.
4
Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010.
J Infect. 2016 Jun;72(6):678-686. doi: 10.1016/j.jinf.2016.03.008. Epub 2016 Mar 18.
5
A cluster of Mycobacterium massiliense keratitis in foundry workers.
Clin Microbiol Infect. 2016 Apr;22(4):386.e5-386.e8. doi: 10.1016/j.cmi.2015.12.014. Epub 2015 Dec 23.
6
Investigation of Mycobacterium abscessus outbreak among cystic fibrosis patients, Hawaii 2012.
J Hosp Infect. 2016 Oct;94(2):198-200. doi: 10.1016/j.jhin.2016.04.015. Epub 2016 May 6.
7
Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study.
Eur Respir J. 2017 Mar 8;49(3). doi: 10.1183/13993003.01429-2016. Print 2017 Mar.
8
Nontuberculous Mycobacteria, Botswana, 2011-2014.
Emerg Infect Dis. 2019 Jul;25(7):1401-1403. doi: 10.3201/eid2507.181440.
9
Clinical relevance of nontuberculous Mycobacteria, Oman.
Emerg Infect Dis. 2009 Feb;15(2):292-4. doi: 10.3201/eid1502.080977.
10
Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
BMC Pulm Med. 2018 Nov 9;18(1):168. doi: 10.1186/s12890-018-0728-z.
引用本文的文献
1
Evaluation of the Standard M10 MTB/NTM Molecular Test for the Rapid Identification of Tuberculous and Nontuberculous Mycobacteria in Liquid Cultures.
Pathogens. 2025 May 22;14(6):517. doi: 10.3390/pathogens14060517.
2
CT‑based radiomics analysis of consolidation characteristics in differentiating pulmonary disease of non‑tuberculous mycobacterium from pulmonary tuberculosis.
Exp Ther Med. 2024 Jan 24;27(3):112. doi: 10.3892/etm.2024.12400. eCollection 2024 Mar.
3
Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022.
Front Cell Infect Microbiol. 2023 Oct 31;13:1282902. doi: 10.3389/fcimb.2023.1282902. eCollection 2023.
4
Performance of Interferon-γ Release Assays in Patients with Infection.
Infect Drug Resist. 2022 Dec 28;15:7727-7732. doi: 10.2147/IDR.S385570. eCollection 2022.
5
[Clinical Characteristics of Nontuberculous Mycobacterium Infection Cases in Sichuan, China in 2016-2021: A Retrospective Study].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):890-895. doi: 10.12182/20220960503.
6
A Review on Mycobacteriophages: From Classification to Applications.
Pathogens. 2022 Jul 7;11(7):777. doi: 10.3390/pathogens11070777.
7
Prevalence of Culture-Confirmed Tuberculosis Among Patients with Nontuberculous Mycobacterial Disease.
Infect Drug Resist. 2022 Jun 17;15:3097-3101. doi: 10.2147/IDR.S363765. eCollection 2022.
8
Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004-2019.
BMJ Open. 2021 Jun 16;11(6):e044349. doi: 10.1136/bmjopen-2020-044349.
9
Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey.
Infect Dis Poverty. 2021 Apr 29;10(1):59. doi: 10.1186/s40249-021-00844-1.
10
Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019.
Infect Drug Resist. 2020 Nov 13;13:4133-4145. doi: 10.2147/IDR.S277203. eCollection 2020.
本文引用的文献
1
Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger?
PLoS Negl Trop Dis. 2010 Apr 27;4(4):e615. doi: 10.1371/journal.pntd.0000615.
2
Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
Chin Med J (Engl). 2010 Jan 20;123(2):184-7.
3
Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008.
Emerg Infect Dis. 2010 Feb;16(2):294-6. doi: 10.3201/eid1602.090675.
4
Non-tuberculous mycobacteria in China.
Scand J Infect Dis. 2007;39(2):138-41. doi: 10.1080/00365540600951234.
5
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
6
Identification of non-tuberculous mycobacteria: 16S rRNA gene sequence analysis vs. conventional methods.
Scand J Infect Dis. 2000;32(1):47-50. doi: 10.1080/00365540050164218.
7
The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong.
Respir Med. 1995 Jan;89(1):3-8. doi: 10.1016/0954-6111(95)90063-2.
Zotero 插件